Assessing the real-world safety of fenofibric acid for hyperlipidemia: results from WHO-VigiAccess and FAERS databases.

Front Med (Lausanne) · 2025 · PMC12634654 · PMID 41282005

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Overall, WHO-VigiAccess does not exhibit a clear trend in reporting proportions, whereas FAERS shows a general decline in adverse event reports since 2009.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.